Can the O-Shot help with vaginal dryness?
Can the O-Shot help with vaginal dryness? | WHC Clinical FAQ
Can the O-Shot improve vaginal tissue quality?
Evidence-aware
Safety focused
Women’s Health Clinic FAQ
Can the O-Shot help with vaginal dryness?
Vaginal dryness can affect comfort, confidence and intimacy, but it is not always caused by the same problem. The useful first step is to understand whether dryness is linked to hormones, tissue change, irritation, medication, pain or arousal.
Direct answer
The O-Shot may help selected patients with vaginal dryness when symptoms appear linked to local tissue quality, blood flow, sensitivity or low-oestrogen tissue change. It uses platelet-rich plasma from your own blood, injected after assessment, with the aim of supporting tissue repair and lubrication response. It is not a first-line answer for every cause of dryness and should not replace menopause care, infection checks, vulval skin assessment or appropriate medical treatment.
A consultation helps separate dryness at rest, dryness during sex, friction, soreness, burning, pain and reduced arousal, because each pattern may point to a different treatment route.
Educational only. Suitability must be confirmed after consultation. Results vary. Not a cure.
At a glance
These are the key points to understand before considering PRP for vaginal dryness.
At a glance
Dryness and PRP
What it is
Platelet-rich plasma prepared from a blood sample and injected into selected intimate tissue.
May suit
Selected patients with dryness linked to tissue quality, comfort or low-oestrogen change.
Evidence status
Early evidence is developing; protocols and individual response vary.
Response time
Tissue response is gradual and may take several weeks to months.
Important suitability note
Dryness should be assessed before treatment, especially if there is pain, bleeding, discharge, infection symptoms or new urinary change.
Menopause
PRP
Assessment
Aftercare
Detailed answer
How PRP may fit into dryness care
The O-Shot is best understood as one possible tissue-support option, not as a single solution for every type of vaginal dryness.
Clinical context
Vaginal dryness can come from low oestrogen, vulval irritation, infection, medication, pelvic-floor tension, pain, arousal changes or skin conditions. PRP may be discussed only after these possibilities have been considered.
Lubrication
Low oestrogen
Alternatives
What the O-Shot is
A small blood sample is processed to concentrate platelets. The platelet-rich plasma is then injected into carefully selected intimate tissue after consent and numbing.
How it may work
Platelet signalling proteins are involved in repair pathways, including collagen support, blood-vessel formation and tissue hydration. These mechanisms are relevant to comfort and lubrication, but response is individual.
What it does not replace
PRP does not replace diagnosis, vaginal oestrogen discussion when low oestrogen is the main driver, treatment for infection, vulval skin care or pelvic-floor assessment.
Why symptoms matter
Dryness at rest, friction during sex, burning, soreness, bleeding, discharge and pain can point to different causes, so they should not be grouped into one treatment promise.
What this means in practice
If the main issue is low-oestrogen tissue change, established options such as vaginal moisturisers, lubricants and local hormone discussion may be relevant before or alongside any regenerative treatment.
If PRP is suitable, the aim is usually gradual tissue support rather than an immediate lubrication effect. Non-response should lead to reassessment, not automatic repetition.
Patient safety
Why proper assessment matters
Dryness can feel simple, but the cause may be hormonal, inflammatory, medication-related, infection-related, pain-related or linked to arousal and pelvic-floor response.
It identifies the cause
The right treatment depends on whether dryness is linked to low oestrogen, irritation, infection, vulval skin change, medication, pain or arousal.
It protects safety
Bleeding, unusual discharge, fever, severe pain, new numbness or urinary change should be reviewed before elective intimate treatment.
It avoids over-treatment
Some patients need moisturisers, lubricants, menopause care, vulval treatment, pelvic-floor support or psychosexual support rather than PRP first.
It sets expectations
PRP response is gradual and variable. It may support tissue quality, but it cannot promise predictable lubrication for every patient.
A careful symptom map is more useful than a treatment label
The strongest consultation starts by asking what dryness means for you: dryness all the time, dryness during sex, soreness, friction, burning, tearing, reduced arousal or pain.
That distinction helps the clinician decide whether PRP is worth discussing, whether another pathway should come first, or whether combined care is more appropriate.
Considerations
What to consider before booking
Before choosing the O-Shot for vaginal dryness, it is important to understand the cause, the evidence limits, the procedure, the aftercare and the alternatives.
Consultation priorities
Your clinician should review symptoms, menopause history, medication, vulval skin, pain, infections, urinary symptoms, previous treatments and your goals before discussing PRP.
Examination
Consent
Follow-up
Before treatment
You may need review for infection, abnormal bleeding, vulval skin change, pelvic pain, medication effects or menopause-related tissue change before PRP is considered.
During the procedure
The appointment usually involves consent, cleansing, a blood draw, centrifuge preparation, numbing and fine injections. Patients may feel pressure, brief stinging or mild discomfort.
Aftercare
Aftercare commonly includes avoiding sex, baths and swimming for 24 to 48 hours while injection points settle, plus clear advice on what symptoms to report.
Medication review
Some protocols advise avoiding NSAIDs such as ibuprofen or aspirin around PRP treatment because platelet activity is part of the intended tissue response.
Practical expectations
Pricing and treatment plans should be confirmed on the /pricing/ page or with the clinic before booking; they should not be guessed from competitor pages.
A follow-up discussion is useful if symptoms do not improve, if discomfort persists, or if the pattern suggests a different underlying cause.
Common concerns and myths
Common misunderstandings
Clear information matters because vaginal dryness is often marketed as though one treatment can solve every intimate symptom.
Myth: one injection solves all dryness
Reality: dryness has several possible causes. PRP may be relevant for selected tissue-related concerns, but infection, skin disease, pain and hormone-related symptoms may need different care.
Myth: dryness and low libido are the same
Reality: lubrication, desire, arousal, comfort and pain are linked but different. A treatment plan should not merge them into one promise.
Myth: PRP replaces menopause treatment
Reality: PRP does not replace appropriate menopause assessment or local oestrogen discussion when low oestrogen is the main driver of tissue change.
Evidence and uncertainty
Research into vaginal PRP is growing, including reviews and clinical studies, but preparation methods, injection protocols and outcome measures vary. That is why cautious language is important.
Alternatives and combined care
Moisturisers, lubricants, local hormone options, pelvic-floor care, vulval dermatology review and psychosexual support may be more appropriate first or may sit alongside PRP.
Safety checklist
Safety checklist
Use these questions to decide whether the next step should be consultation, further assessment, treatment planning or urgent advice.
Has the cause been assessed?
Dryness should be mapped by symptom pattern, medical history, medication, menopause status and any pain, bleeding, discharge or urinary change.
Are symptoms stable?
New, severe, worsening or unexplained symptoms should be reviewed before an elective intimate procedure.
Are options clear?
Ask how PRP compares with moisturisers, lubricants, local oestrogen discussion, pelvic-floor support or other relevant care.
Is follow-up planned?
You should know what to expect, what aftercare to follow, when to seek help and when the response will be reviewed.
Reassuring signs
It is more reasonable to discuss PRP when symptoms have been assessed, red flags are absent, goals are realistic and alternatives have been explained.
Realistic goals
Aftercare clear
Reasons to pause
Pause and seek medical review if dryness is accompanied by unexplained bleeding, unusual discharge, fever, severe pain, new numbness, vulval lesions or sudden urinary change.
Infection signs
New numbness
When to escalate
When to seek medical help
Some symptoms should be assessed promptly before any elective intimate treatment is considered. Use NHS 111 online
Severe or worsening pain
Seek medical advice if pelvic, vulval or vaginal pain is severe, sudden, worsening or unexplained.
Bleeding or discharge
Unexplained bleeding, bleeding after sex, foul-smelling discharge or unusual discharge should be reviewed before treatment.
Infection signs
Fever, feeling unwell, spreading redness, pus, worsening swelling or urinary infection symptoms need prompt clinical advice.
New numbness or bladder change
Sudden genital numbness, numbness into the legs, new weakness or sudden bladder change should be assessed urgently.
Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.
Regulatory resources
Authoritative resources
These resources support assessment-led, evidence-aware information about vaginal dryness, menopause-related symptoms and investigational intimate treatments.
NHS guidance on vaginal dryness
NHS patient guidance explains common causes of vaginal dryness and when to seek help.
NICE menopause guideline
NICE guidance supports evidence-aware discussion of menopause symptoms, treatment options and individualised care.
British Menopause Society GSM consensus statement
The BMS consensus statement supports clinical framing of genitourinary syndrome of menopause and related dryness symptoms.
Next step
Book a clinical consultation
A consultation can confirm whether PRP is worth discussing, whether another pathway should come first, and what realistic outcomes and aftercare would look like.
▶ View Research Sources (12 Sources)
These 12 source names are selected from 24 display-ready sources, with a raw audit trail of 471 imported records. Additional reviewed material included UK clinical guidance, professional society guidance, peer-reviewed clinical papers, evidence reviews; duplicate, low-relevance and non-clinical records were removed before display.
Educational only. This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. The O-Shot is an off-label, investigational PRP procedure for this context, and suitability must be confirmed after an individual consultation. Results vary. Not a cure.
